Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2023 Feb 8;42:43. doi: 10.1186/s13046-023-02613-4

Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395

Guoliang Sun 1,2,#, Hui Zhou 1,2,#, Ke Chen 1,2, Jin Zeng 1,2, Yangjun Zhang 1,2, Libin Yan 1,2, Weimin Yao 1,2, Junhui Hu 2,3, Tao Wang 4, Jinchun Xing 4, Kefeng Xiao 5, Lily Wu 3, Zhangqun Ye 1,2, Hua Xu 1,2,
PMCID: PMC9906818  PMID: 36755337

Retraction Note: J Exp Clin Cancer Res 39, 116 (2020)

https://doi.org/10.1186/s13046-020-01606-x

The Editor-in-Chief has retracted this article because of the following concerns:

  • Within Figure 3D, the panels (OS-RC-2 vs sh-CCDC50#1) and (OS-RC-2 vs sh-CCDC50#2) overlap.

  • Figure 3H contained a panel (CCDC50-S vs whole) with missing sections within the image.

  • An incorrect panel (OS-RC-2 vs sh-HnRNP A1+CCDC50-FL) was provided for supplementary figure 5B.

The data reported in this article are therefore unreliable.

Guoliang Sun and Hua Xu agree to this retraction. Hui Zhou has agreed to this retraction but not to the wording of this retraction notice. Ke Chen, Jin Zeng, Yangjun Zhang, Libin Yan, Weimin Yao, Junhui Hu, Tao Wang, Jinchun Xing, Kefeng Xiao, Lily Wu and Zhangqun Ye have not responded to any correspondence from the publisher about this retraction.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Guoliang Sun and Hui Zhou contributed equally to this work.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES